Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Share News (SPH)

  • There is currently no data for SPH

Tuesday broker round-up UPDATE

Tue, 29th Jul 2014 09:37
Abderdeen Asset Management: Berenberg cuts target price from 530p to 510p and maintains a buy recommendation.African Barrick Gold: Numis takes target price from 260p to 330p upgrading from hold to buy.Anglo American: Deutsche Bank increases target price from 1590p to 1650p and reiterates a hold recommendation. Investec raises target price from 1630p to 1760p and keeps a hold recommendation.APR Energy: Investec places its target price (prev.: 880p) under review, while keeping a hold recommendation.Barclays: Numis upgrades from add to buy with a target price of 280p.Brammer: Investec cuts target price from 450p to 435p, while upgrading from hold to buy.BSkyB: Westhouse Securities upgrades from neutral to add with a target price of 985p.BTG: Jefferies ups target price from 525p to 760p upgrading from hold to buy.Compass Group: Deutsche Bank raises target price from 1025p to 1105p and retains a buy recommendation.Daily Mail & General Trust: Credit Suisse reinstates with a target price of 1040p and an outperform rating.Drax Group: Goldman Sachs cuts target price from 1098p to 1052p retaining a strong buy recommendation.Gem Diamonds: FinnCap ups target price from 211p to 261p and maintains a buy recommendation. Westhouse Securities ups target price from 220p to 235p and reiterates its buy recommendation.GKN: Numis upgrades from add to buy with a target price of 435p.GlaxoSmithKline: Berenberg reduces target price from 1740p to 1520p, while leaving its hold recommendation unchanged.Hiscox: Deutsche Bank cuts target price from 658p to 646p staying with its sell recommendation. Canaccord Genuity shifts target price from 705p to 710p and reiterates a hold recommendation.HSBC Holdings: Deutsche Bank reduces target price from 640p to 593p and reiterates a hold recommendation.Hutchison China Meditech: Panmure Gordon raises target price from 950p to 1200p keeping a buy recommendation.Informa: Canaccord Genuity cuts target price from 535p to 515p staying with its hold recommendation.Jardine Lloyd Thompson: Numis cuts target price from 1190p to 1120p downgrading from add to hold.Ladbrokers: Deutsche Bank lowers target price from 177p to 165p and keeps a buy recommendation.Lancashire Holdings: Berenberg reduces target price from 720p to 666p keeping a hold recommendation.Pace: Numis reduces target price from 420p to 360p and reiterates a hold recommendation.Petra Diamonds: Beaufort upgrades to buy. Numis ups target price from 220p to 240p, while downgrading from buy to add.Provident Financial: Espirito Santo raises target price from 1808p to 2012p and retains a neutral rating.Reckitt Benckiser: Credit Suisse raises target price from 5200p to 5500p and maintains an outperform rating. Numis downgrades from add to hold with a target price of 5600p.Sinclair IS Pharma: Jefferies lowers target price from 50p to 45p staying with its buy recommendation.Spectris: Goldman Sachs reduces target price from 3050p to 2770p and keeps its strong buy recommendation. Credit Suisse reduces target price from 2560p to 2370p and leaves its outperform rating unaltered. Canaccord Genuity reduces target price from 2700p to 2400p and downgrades from buy to hold.Sweett Group: N+1 Singer cuts target price from 61p to 45p retaining a buy recommendation.Tesco: Shore Capital upgrades from sell to hold.Treatt: Investec moves target price from 150p to 160p reiterating a hold recommendation.Tullett Prebon: Numis places both its target price (prev.: 299p) and its reduce rating under review. Liberum Capital places its target price (prev.: 240p) under review with a sell recommendation. Canaccord Genuity places both its target price and recommendation under review.William Hill: Deutsche Bank cuts target price from 435p to 415p leaving its buy recommendation unchanged.Zoopla Property: Credit Suisse initiates with a target price of 290p and an outperform rating.7Digital: Investec initiates with a target price of 37p and a buy recommendation.

Related News

LONDON MARKET CLOSE: Segro bid boosts FTSE 100 as gold and oil sink
1 hour ago

LONDON MARKET CLOSE: Segro bid boosts FTSE 100 as gold and oil sink

(Alliance News) - The FTSE 100 closed higher on Wednesday as gains in property stocks and housebuilders offset a slump in mining stocks as metals pric...

GSK launches tender offer for USD10.6 billion purchase of Nuvalent
2 hours ago

GSK launches tender offer for USD10.6 billion purchase of Nuvalent

(Alliance News) - GSK PLC on Wednesday said it has launched the tender offer for its previously announced acquisition of US-based cancer drug develope...

LONDON BROKER RATINGS: Berenberg says buy NatWest, hold Lloyds
8 hours ago

LONDON BROKER RATINGS: Berenberg says buy NatWest, hold Lloyds

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Sinclair Pharma News

GLG Partners Doubles Sinclair Pharma Stake To 10.8% From 5.1% (ALLISS)
23 Oct 2018

GLG Partners Doubles Sinclair Pharma Stake To 10.8% From 5.1% (ALLISS)

LONDON (Alliance News) - Sinclair Pharma PLC said Tuesday that GLG Partners LP doubled its stake in the company to 10.81%.GLG's previous holding in th...

Toscafund Asset Management Divests Entire Sinclair Pharma Holding (ALLISS)
19 Oct 2018

Toscafund Asset Management Divests Entire Sinclair Pharma Holding (ALLISS)

LONDON (Alliance News) - Sinclair Pharma PLC said Friday that Toscafund Asset Management LLP divested its entire stake in the company.Prior to selling...

Weiss Asset Management More Than Doubles Sinclair Pharma Stake (ALLISS)
17 Oct 2018

Weiss Asset Management More Than Doubles Sinclair Pharma Stake (ALLISS)

LONDON (Alliance News) - Sinclair Pharma PLC said Wednesday that Weiss Asset Management LP more than doubled its stake in the company raising it to 12...

Sinclair Pharma H1 losses widen as revenue rises
27 Sep 2018

Sinclair Pharma H1 losses widen as revenue rises

(Sharecast News) - Dermatology product maker Sinclair Pharma said first half pre-tax losses widened to £11.4m from £7.8m.

Sinclair Pharma Interim Loss Deepens On One-Off Charges, Revenue Grows
27 Sep 2018

Sinclair Pharma Interim Loss Deepens On One-Off Charges, Revenue Grows

LONDON (Alliance News) - Aesthetic dermatology firm Sinclair Pharma PLC said Thursday its interim loss deepened amid one-off costs, meanwhile revenue ...

Sinclair Pharma Takeover Moves Closer As Conditions Are Met
18 Sep 2018

Sinclair Pharma Takeover Moves Closer As Conditions Are Met

LONDON (Alliance News) - Sinclair Pharma PLC said Tuesday the pre-conditions for Huadong Medicine Aesthetics Investment (Hong Kong) Ltd's takeover hav...

LONDON MARKET OPEN: Stocks Mixed, Micro Focus Climbs On Buyback
29 Aug 2018

LONDON MARKET OPEN: Stocks Mixed, Micro Focus Climbs On Buyback

LONDON (Alliance News) - Stock prices in London were mixed early Wednesday, with Micro Focus and CRH helping the large-cap index to out-perform after ...